Shire Laboratories Inc., a subsidiary of Shire plc has filed a lawsuit in the U.S. District Court for the District of New Jersey against Corepharma LLC for infringement of Shire Laboratories' U.S. Patent Nos. 5,326,570 ("'570 Patent") and 5,912,013 ("'013 Patent").
Such lawsuit is the result of Corepharma’s filed Abbreviated New Drug Application (ANDA) for generic versions of Shire's 100 mg, 200 mg, and 300 mg CARBATROL® products that Corepharma is seeking FDA approval of to market its generic products prior to the expiration of the '570 and '013 Patents.
Read more at Shire plc Press Release (pdf file).
Comment Preview